Uses of cadimelcox 15

Cadimelcox 15 is a pain reliever, antipyretic, non-steroidal anti-inflammatory drug, a drug for the treatment of gout and bone and joint diseases. produced by US Pharma USA Joint Stock Company - VIETNAM, and registered by US Pharma USA Joint Stock Company. Cadimelcox 15 medicine contains the main ingredient Meloxicam 15mg and is packaged in the form of Tablets
Cadimelcox 15 is indicated for the treatment of long-term symptoms, pain caused by chronic inflammation in: Osteoarthritis pain (joint damage, degeneration, degenerative joint disease). Osteoarthritis), ankylosing spondylitis, rheumatoid arthritis, ...
Drug Cadimelcox 15 has the main ingredient meloxicam, a non-steroidal anti-inflammatory drug (NSAID) belonging to the oxicam family, it has anti-inflammatory properties. inflammation, relieve pain and reduce fever. Cadimelcox 15 has very strong anti-inflammatory properties for all types of inflammation.

2.1. Dosage and use of Cadimelcox 15: Patients with rheumatoid arthritis, ankylosing spondylitis: 15 mg per day. Depending on the response to therapy, the dose may be reduced to 7.5 mg per day. Osteoarthritis: 7.5 mg per day. If necessary, the dose can be increased to 15 mg per day. The recommended dose of Cadimelcox 15 injection is 15 mg once daily. Patients at high risk of adverse reactions: Treatment is initiated at a dose of 7.5 mg daily. Patients with severe renal failure must be on hemodialysis: The dose should not exceed 7.5 mg per day. Maximum recommended daily dose of Cadimelcox 15: 15 mg. When using Cadimelcox 15 in combination in the case of multiple presentations, the total daily dose of Meloxicam administered as tablets and injections should not exceed 15 mg. Cadimelcox 15 intramuscular injection is only used in the treatment in the first days. After that, oral therapy can be continued i.e. tablets. Meloxicam must be injected deep into the muscle. Absolutely do not use the ampoule of Cadimelcox 15 main ingredient meloxicam in the form of intramuscular injection for intravenous infusion. Pediatric doses have not been established for Meloxicam injection and oral tablets, so Meloxicam is restricted to adults only. Tablets are taken with water or other liquid, the drug is not reduced when taken with food. 2.2. Overdose, missed dose and treatment when taking Cadimelcox 15 What to do in case of overdose Cadimelcox 15 Prescription drugs require a prescription from a doctor or pharmacist. Over-the-counter medicines require a leaflet from the manufacturer. Carefully read and follow the exact dose indicated on the prescription or medication leaflet. When taking an overdose of Cadimelcox 15, it is necessary to stop taking it, immediately notify the doctor or pharmacist when there are abnormal symptoms
Treatment:
Unusual manifestations of overdose need to notify the doctor or medical person in charge. economic. In case of overdose of Cadimelcox 15, there are symptoms that need emergency: Family members should bring medical records, all prescriptions/pots of medicine that have been and are being used so that doctors can quickly diagnose and treat
What to do if you miss a dose of Cadimelcox 15 Usually the medicine can be taken in about 1-2 hours than prescribed in the prescription. Unless there is a strict rule about the time of use, the medicine can be taken a few hours after forgetting. However, if the time is too far from the time you need to drink, you should not take it, which can be dangerous for the body. It is necessary to strictly adhere to or consult a doctor before making a decision.

Contraindications:
Do not use Meloxicam in the following patients:
Patients with a history of hypersensitivity to meloxicam or any of its components Patients with cross-sensitivity to Aspirin and non-steroidal anti-inflammatory drugs. other. The patient has a history of asthma, nasal polyps, angioedema or urticaria after taking aspirin or other nonsteroidal anti-inflammatory drugs. Patients with advanced peptic ulcer. Patients with severe liver failure. Patients with severe renal failure without hemodialysis. Children under 15 years old. Pregnant and lactating women. Normally, people who are allergic to any of the ingredients in the drug should not use the drug. Other cases are specified in the drug leaflet or doctor's prescription. Contraindication to the drug Cadimelcox 15 must be understood as an absolute contraindication. Use in pregnant and lactating women: Meloxicam should not be used in pregnant or lactating women even though no teratogenic effects have been observed in the following cases. preclinical trials. Effects of drugs on driving and operating machines: There have been no studies on the effects of the drug on the ability to drive and use machines. However, if side effects such as dizziness and drowsiness occur, you should avoid driving or operating machinery. Note during pregnancy Pregnant women taking Cadimelcox 15 should consider and consult a doctor or pharmacist before taking the drug. Even tested drugs still have risks when used.
Note the breastfeeding period Mothers need to carefully weigh the benefits and risks for mother and baby. Do not arbitrarily use the drug without carefully reading the instructions for use and instructions of the doctor to protect the mother and baby

General precautions for use of Cadimelcox 15 Cadimelcox 15 should not be used as a substitute for corticosteroids or for the treatment of corticosteroid deficiencies.
Abruptly stopping corticosteroids can make the condition worse. If a patient decides to discontinue corticosteroid therapy, the dose should be gradually reduced in patients on long-term corticosteroid therapy.
Use caution in patients with upper gastrointestinal disease or on anticoagulant therapy.
Discontinue the drug when there are adverse manifestations in the skin, mucous membranes, peptic ulcer or gastrointestinal bleeding.
Closely monitor urine volume and renal function in patients with decreased renal volume and blood flow.

Gastrointestinal: Abdominal pain, diarrhea, dyspepsia, flatulence, vomiting and transient abnormalities due to changes in liver function parameters. Hematology: anemia, blood count disorders: white blood cell disorders, thrombocytopenia. Concomitant use with drugs that are toxic to the bone marrow, especially methotrexate, will be a favorable factor for the decline of blood cells. Skin: Itching, skin rash, urticaria, stomatitis, photosensitivity. Respiratory system: Onset of acute asthma attacks (very rare). Central nervous system: Dizziness, headache, tinnitus, somnolence. Cardiovascular system: Edema, hypertension, palpitations, flushing. Urinary system: increased blood creatinine and/or blood urea. Hypersensitivity reactions: mucosal edema and anaphylactoid reactions Note: Inform the doctor about the side effects encountered when using the drug.
Usually the side effects or unwanted effects (Adverse Drug Reaction (ADR) unwanted effects will go away when the drug is stopped. If there are rare side effects that are not mentioned in the leaflet. Inform your doctor or medical officer immediately if you suspect any side effects of Cadimelcox 15
.